NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
NATIONAL INSTITUTE ON DRUG ABUSE EPIDEMIOLOGIC ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Ketamine and Rohypnol did not have a presence at all.<br />
Fifty-six percent of the patients reporting MDMA use<br />
were male, and 38 percent were Hispanic (followed by<br />
22 percent White and Black). More than one-half of<br />
the MDMA users (56 percent) were between 12 and 24<br />
years of age. Of the 122 complaints, the three most<br />
frequently reported complaints were altered mental<br />
status (40 complaints), intoxication (36 complaints),<br />
and psychiatric condition (31 complaints). Methamphetamine-using<br />
patients were most likely to be admitted<br />
to a psychiatric inpatient ward (50 percent) or discharged<br />
(20 percent).<br />
California Poison Control System calls involving<br />
exposure to ecstasy among Los Angeles County residents<br />
have decreased consistently over recent years,<br />
from a high of 56 in 2000 to a low of 16 in 2003 (exhibit<br />
8a). In the first half of 2004 alone, however, 12<br />
calls relating to ecstasy exposure were reported. If an<br />
equal number of calls are made in the second half of<br />
2004, the overall number will exceed the 2003 level.<br />
Between January 2003 and June 2004, slightly more<br />
callers reporting exposure to ecstasy were male (57<br />
percent) than female (43 percent), and 64 percent<br />
were between the ages of 13 and 25 (exhibit 9). In<br />
addition to calls relating to ecstasy exposure, a total<br />
of 14 GHB exposure calls, 4 ketamine calls, and 3<br />
Rohypnol calls were recorded between January 2000<br />
and June 2004.<br />
The California Poison Control System also kept track<br />
of calls relating to Coricidin HBP and dextromethorphan<br />
(DXM) exposures. Between January 2003 and<br />
June 2004, 50 Coricidin HBP calls and 17 DXM calls<br />
were logged in the system (exhibit 9). Fifty-two percent<br />
of Coricidin HBP calls and 58 percent of DXM<br />
calls were male. Furthermore, 84 percent of the Coricidin<br />
HBP calls and 58 percent of the DXM calls<br />
were made because of exposure to individuals<br />
younger than 18. Eighteen to 24-year-olds represented<br />
an additional 16 percent of the Coricidin HBP<br />
calls and 21 percent of the DXM calls.<br />
According to CHKS data for the 2003–2004 school<br />
year (exhibit 10), 5.5 percent of all Los Angeles<br />
County secondary school students (including 7th, 9th,<br />
and 11th graders, and a small sample of nontraditional<br />
students) who responded to the survey had ever<br />
used ecstasy. Current use of ecstasy was not assessed,<br />
although a question regarding past-6-month use of<br />
psychedelics, ecstasy, or other club drugs was included<br />
in the survey. Overall, 6.2 percent of all respondents<br />
reported use of these drugs (exhibit 11).<br />
By grade, 6 percent of 9th graders and 5 percent of<br />
11th graders answered in the affirmative.<br />
<strong>EPIDEMIOLOGIC</strong> TRENDS IN <strong>DRUG</strong> <strong>ABUSE</strong>—Los Angeles County<br />
According to NFLIS data based on 54,240 analyzed<br />
items reported by participating laboratories within Los<br />
Angeles County between October 2003 and September<br />
2004, less than 1 percent (288) of all items analyzed<br />
were found to be MDMA, GHB, or ketamine. Of those<br />
three club drugs, MDMA was most likely to be detected;<br />
it represented 81 percent of the club drug samples<br />
analyzed by NFLIS. GHB represented an additional<br />
12 percent of the samples, and ketamine accounted<br />
for 7 percent.<br />
According to NDIC, the majority of MDMA available<br />
in Los Angeles is transported directly from<br />
Western Europe. Los Angeles is a source of both<br />
wholesale and midlevel amounts of MDMA, which is<br />
destined for markets around the United States, including<br />
Pacific, Southwest, and West Central States<br />
(NDIC 2004). Israeli and Russian criminal groups<br />
control the wholesale distribution, and independent<br />
dealers (usually White males) are responsible for<br />
retail marketing and distribution. Mail service and air<br />
travel are the two most likely ways to transport the<br />
product into Los Angeles. Within Los Angeles, Israeli<br />
and Russian traffickers control the distribution<br />
at the wholesale level.<br />
With the exception of GHB, wholesale and retail<br />
prices for club drugs remained stable since the June<br />
2004 report. In multiple quantities, MDMA has a<br />
wholesale price of $12 per pill or capsule (exhibit<br />
13). At the retail level, ecstasy usually sells for $20–<br />
$40 per pill. A standard dose of ecstasy is 60–150<br />
milligrams, which is equivalent to one or two pills. In<br />
Los Angeles, ecstasy “boats” continue to be mentioned.<br />
A boat contains 1,000 MDMA pills and sells<br />
for $8,000. Flunitrazepam (Rohypnol), when available,<br />
has a retail value of $6–$10 for a 1-milligram<br />
pill. On the street, ketamine sells for $100–$200 per<br />
10-milliliter vial. In addition, ketamine retails for $20<br />
for two-tenths grams of powder. The wholesale price<br />
for GHB increased since the last report. A gallon<br />
sells for $275–$300, and a liter sells for $80–$100. A<br />
16-ounce bottle of GHB, which once ranged from<br />
$65 to $100, now sells for $120. Capfuls can still be<br />
purchased for $5–$20 each. The vast majority of<br />
GHB users ingested the drug as a liquid, either in<br />
straight shots or mixed with a drink.<br />
INFECTIOUS DISEASES RELATED TO <strong>DRUG</strong> <strong>ABUSE</strong><br />
A cumulative total of 48,510 adult/adolescent AIDS<br />
cases were reported in Los Angeles County through<br />
June 30, 2004. Of those cases, 996 were reported<br />
between January 1, 2004, and June 30, 2004. Currently,<br />
approximately 19,700 Los Angeles County<br />
Proceedings of the Community Epidemiology Work Group, Vol. II, January 2005 109